RxDoctor Payments Data

Jarrett Boroniec, DO

Orthopaedic Surgery · Brooklyn, NYNPI 1083068472

Payments from drug & device makers

$8,262in general payments, 2019–2025

Across 52 payments — averaging $158.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$6K
  • Stryker$752
  • Polaris Technology Solutions LLC$573
  • Johnson & Johnson$382
  • Gotham Surgical Solutions & Devices, Inc.$337
  • Smith+Nephew$320
  • plus $286 from 4 others

What the payments were for

  • Travel & lodging$2,23127%
  • Food & beverage$2,43229%
  • Education$3,60044%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex26$5,612
Stryker7$752
Polaris Technology Solutions LLC1$573
Johnson & Johnson5$382
Gotham Surgical Solutions & Devices, Inc.6$337
Smith+Nephew2$320
Spinal Elements, Inc.2$151
Heraeus Medical, LLC.1$82
Vertex1$27
Fidia Pharma USA Inc.1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,262 in reported general payments places this provider in the 60th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$62,370
Medicare patients
105
Services billed
476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam24$39

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →